Gain A Better Understanding of Psoriasis on CME Webcast

OSUWexnerbloglogo2014 Gain A Better Understanding of Psoriasis on CME Webcast. Over the centuries, thousands of treatments have been tried and thousands of treatments have failed. But the good news is that in the past few years there have been effective new biologic agents developed that are offering hope to patients with the most severe cases of psoriasis. Joining us on our webcast to discuss the diagnosis and management of psoriasis is dermatologist and Assistant Professor of Internal Medicine, Dr. Jessica Kaffenberger.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: RECOGNIZE the different types of psoriasis and how to effectively treat them; DESCRIBE the pathogenesis of psoriasis and how it correlates with the newest therapies; and IDENTIFY frequent psoriasis co-morbidities that affect medication management.

You’ll also learn about the following:

  • The etiology of psoriasis
  • New directions in treating psoriasis
  • The role of skin biopsy
  • Psoriasis versus eczema
  • Long-term prognosis for patients with psoriasis
  • Relationship of diet, exercise, and sunlight with psoriasis
  • Deodorants and common skin lotions
  • Swimming with psoriasis
  • Treatment of psoriatic arthritis
  • Precautions for patients taking methotrexate
  • Genital psoriasis and sexual health

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

On-line Education Discusses Vasculitis and What The Primary Care Physician Needs To Know

OSUWexnerbloglogo2014 On-line Education Discusses Vasculitis and What The Primary Care Physician Needs To Know. Vasculitides such as granulomatosis with polyangiitis are potentially deadly diseases and patients will usually first present to their primary care physician with signs and symptoms of vasculitis. But these diseases can be difficult to diagnose so today on MedNet, we’re going to help you to be able to identify vasculitis in your patients and give you an overview of the treatment of vasculitis. First, to tell you about pulmonary manifestations of vasculitis is pulmonologist and Assistant Professor of Internal Medicine, Dr. Lynn Fussner. And then, to tell you about renal manifestations of vasculitis is nephrologist and Assistant Professor of Internal Medicine Dr. Salem Almaani. And finally, to share about the treatment of vasculitis is rheumatologist and Assistant Professor of Internal Medicine, Dr. Alexa Meara.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: REVIEW the classification and defining features of ANCA-associated vasculitis; and HIGHLIGHT clinical findings that could suggest sinopulmonary manifestations of vasculitis.

You’ll also learn about the following:

  • Presenting signs and symptoms of vasculitis
  • Prognosis of vasculitis
  • When to stop treatment
  • Microscopic polyangiitis
  • Distinguishing between vasculitides by kidney biopsy
  • Whether vasculitis patients with ESRD need to be treated

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

On-line CME Education Discusses Lymphoma

OSUWexnerbloglogo2014 On-line CME Education Discusses Lymphoma. Today, Hodgkin’s disease is curable in most patients with a 5-year survival rate of 86%. But this is only one type of lymphoma and as we’ll see today, hematologists have made enormous strides in the management of all types of lymphoma. Joining our moderator are two lymphoma experts from The Ohio State University and the James Cancer Hospital. Dr. Kami Maddocks is an Associate Professor of Internal Medicine from the Division of Hematology. And Dr. Beth Christian is also a hematologist and Associate Professor of Internal Medicine.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DEFINE the most common types of aggressive lymphomas, identify both urgent initial presentations and urgent complications of treatment, and outline standards of survivorship; and DESCRIBE the features of indolent non-Hodgkin lymphoma including the most common subtypes, follicular lymphoma, marginal zone lymphoma and Waldenström macroglobulinemia.

You’ll also learn about the following:

  • What causes lymphoma
  • The spectrum of lymphomas
  • Stem cell transplant in aggressive lymphomas
  • Whether there a role for “maintenance rituximab”
  • Chronic lymphocytic leukemia versus non-Hodgkin lymphoma
  • Lymphoma mimics
  • Deciding when to biopsy an enlarged lymph node

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

On-line CME on Approach to Pulmonary Nodules Educates Physicians

OSUWexnerbloglogo2014 On-line CME on Approach to Pulmonary Nodules Educates Physicians. The dilemma that clinicians face is what do we do with all of these pulmonary nodules. Joining us on this CME webcast to shed some light on pulmonary nodules and give us a rational approach to their management is pulmonologist and Assistant Professor of Internal Medicine from The Ohio State University, Dr. Edwin Jackson.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the basic approach to management of pulmonary nodules; and UNDERSTAND the difference between nodules identified on lung cancer screening examinations and incidentally discovered pulmonary nodules.

You’ll also learn about the following:

  • Causes of pulmonary nodules
  • Risk stratification and pulmonary nodules
  • Bronchoscopic versus CT-guided needle biopsy
  • Contrast-enhanced versus non-contrast CT scans
  • Whether everyone should get a screening chest CT

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

On-line CME Discussing Multiple Myeloma

OSUWexnerbloglogo2014 On-line CME Discussing Multiple Myeloma. In the past year, there have been 4 new drugs approved to treat multiple myeloma and these are changing the way that we manage patients with this disease. On this CME webcast, we’re going to talk about what multiple myeloma is, how you diagnosis it, and how it is treated. Joining our moderator in the studio is hematologist and Assistant Professor of Internal Medicine from the OSU Wexner Medical Center, Dr. Ashley Rosko. And also from the division of hematology, we have Associate Professor of Internal Medicine, Dr. Yvonne Efebera joining us.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the difference between MGUS, smoldering Myeloma, Symptomatic multiple Myeloma; DESCRIBE the general clinical features of plasma cell myeloma including the diagnosis, and steps required for evaluation; UNDERSTAND Treatment strategy for Newly diagnosed Multiple Myeloma Patients Eligible for Transplant and Newly diagnosed Multiple Myeloma Patients not Eligible for Transplant.

You’ll also learn about the following:

  • Epidemiology of multiple myeloma
  • Prognosis of multiple myeloma
  • When to do a bone marrow biopsy?
  • Screening patients with kidney failure for multiple myeloma
  • Management of hypercalcemia and renal failure in multiple myeloma
  • Autologous versus allogenic stem cell transplant

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.